Instruction for use: HytrinI want this, give me price
Trade name of the drug – Hytrin
Active substance: Terazosinum
Dosage Form: tablets
Composition (per tablet): "Start package": 1 tablet (white) contains terazosin hydrochloride 1 mg and 1 tablet (orange) - 2 mg; in blister 14 pcs. (Table 7. Each dosage), in one blister box.
1 tablet (orange) - 2 mg; per pack 28 pcs.
1 tablet (light brown) - 5 mg; per pack 28 pcs.
1 tablet (green) - 10 mg; per pack 28 pcs.
Drugs affecting the metabolism of the prostate gland and correctors urodynamics
ATX G04CA03 Terazosin
The nosological classification (ICD-10)
I10 Essential (primary) hypertension: hypertension; Arterial hypertension; Arterial hypertension crisis course; Essential Hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Primary hypertension; Arterial hypertension, complications of diabetes; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; arterial Hypertension; malignant Hypertension; Hypertonic disease; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; Isolated systolic hypertension
I15 Secondary hypertension: Arterial hypertension, complications of diabetes; hypertension; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; hypertension; arterial Hypertension; malignant Hypertension; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; hypertension; Arterial hypertension; Arterial hypertension crisis course; renovascular hypertension; Hypertension symptomatic; Renal hypertension; Renovascular hypertension; renovascular hypertension; Symptomatic hypertension
N40 Hyperplasia of prostate gland: Prostate adenoma; BPH; Prostatauxe; prostate Hypertrophy; Dysuric disorders caused by benign prostatic hyperplasia; Dizuricheskie disorder with benign prostatic hyperplasia; Dysuria with prostate cancer; Benign prostatic giperpalaziya; Benign prostatic hyperplasia; Benign prostatic hyperplasia stages 1 and 2; Benign prostatic hyperplasia I degree; Benign prostatic hyperplasia II degree; Benign prostatic hypertrophy; The disease of the prostate gland; Acute urinary retention related to benign prostatic hyperplasia; Benign prostatic hyperplasia stages 1 and 2 in combination with prostatitis; paradoxical ischuria
Pharmacological Properties of Hytrin
Pharmachologic effect - Mode of action - alpha adrenoliticheskoe.
Selectively blocks postsynaptic alpha1-adrenergic receptors decreases the tonus of smooth muscle prostate vessels.
In patients with BPH normalizes urination (alpha1-adrenergic blockade triangle smooth muscle of the bladder neck and proximal urethra, the prostate gland). It is an extension resistance (arterial) blood vessels, reduces peripheral vascular resistance and blood pressure. Reduces pre- and afterload on the heart. Unlike selective blockers, alpha 1 and alpha2 adrenergic receptors causes marked tachycardia. It has a lipid-lowering activity.
Quickly and completely absorbed in the digestive tract. Cmax plasma levels achieved after 1 hour. Intensively binds to blood protein. T1 / 2 -. 12 hours is metabolized in the liver. About 10% is excreted unchanged in the urine and 20% - through the intestines; remainder is excreted in the form of metabolites.
Indications for Hytrin
Prostate adenoma, arterial hypertension.
Contraindications for Hytrin
Hytrin Dosage and Administration
Inside. Hypertension: start with receiving the lowest dose (1 mg), and then it increased to 1-5 mg / day in 1-2 reception. The maximum daily dose - 20 mg.
Prostate adenoma: first taking 1.2 mg, then - 5 mg (clinical effect is achieved). In case of cancellation of treatment, reduce the dose gradually (over several days).
Side effect of Hytrin
Asthenia, violation of clarity of vision, nasal congestion, nausea, peripheral edema, tendency to increase body weight in patients; lower hematocrit, hemoglobin, white blood cells, total protein and albumin in the blood.
It enchases (Mutually) the effect of others. Antihypertensive drugs (dosage should be adjusted). Compatible with analgesic, anti-inflammatory and cardiovascular agents, corticosteroids, and others.
SPECIAL INSTRUCTIONS for Hytrin
It should be borne in mind the effect of "first dose" (orthostatic collapse). Upon termination of the treatment for a few days or longer therapy should be carried out on the original scheme.
Storage conditions of Hytrin
The temperature is not above 40 ° C.
Keep out of the reach of children.
Do not use beyond the expiration date printed on the package.